1. 1223Ledipasvir/Sofosbuvir is Safe and Effective as a Single-Tablet-Regimen for Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus, Including those with Compensated Cirrhosis. (December 2014) Authors: Sulkowski, Mark; Kowdley, Kris; Ruane, Peter; Hawkins, Trevor; Elion, Richard; Workowski, Kimberly; Mills, Anthony; Subramanian, Mani; Ding, Xiao; Seyedkazemi, Star; Hyland, Robert H.; Yang, Jenny C.; Pang, Phillip S.; Mchutchison, John G.; Afdhal, Nezam; Wyles, David Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection. (20th April 2015) Authors: Kowdley, Kris V.; An, Di; Pang, Phillip S.; Wyles, David Journal: Open forum infectious diseases Issue: Volume 2:Number 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection. Issue 4 (29th July 2016) Authors: Abergel, Armand; Metivier, Sophie; Samuel, Didier; Jiang, Deyuan; Kersey, Kathryn; Pang, Phillip S.; Svarovskaia, Evguenia; Knox, Steven J.; Loustaud‐Ratti, Veronique; Asselah, Tarik Journal: Hepatology Issue: Volume 64:Issue 4(2016:Oct.) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus. Issue 7 (27th July 2016) Authors: Chuang, Wan‐Long; Chien, Rong‐Nan; Peng, Cheng‐Yuan; Chang, Ting‐Tsung; Lo, Gin‐Ho; Sheen, I‐Shyan; Wang, Horng‐Yuan; Chen, Jyh‐Jou; Yang, Jenny C.; Knox, Steven J.; Gao, Bing; Garrison, Kimberly L.; Mo, Hongmei; Pang, Phillip S.; Hsu, Yu‐Chun; Hu, Tsung‐Hui; Chu, Chi‐Jen; Kao, Jia‐Horng Journal: Journal of gastroenterology and hepatology Issue: Volume 31:Issue 7(2016:Jul.) Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ledipasvir‐sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens. Issue 6 (27th April 2015) Authors: Wyles, David; Pockros, Paul; Morelli, Giuseppe; Younes, Ziad; Svarovskaia, Evguenia; Yang, Jenny C.; Pang, Phillip S.; Zhu, Yanni; McHutchison, John G.; Flamm, Steven; Lawitz, Eric Journal: Hepatology Issue: Volume 61:Issue 6(2015:Jun.) Page Start: 1793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data. Issue 2 (18th December 2015) Authors: Wilder, Julius M.; Jeffers, Lennox J.; Ravendhran, Natarajan; Shiffman, Mitchell L.; Poulos, John; Sulkowski, Mark S.; Gitlin, Norman; Workowski, Kimberly; Zhu, Yanni; Yang, Jenny C.; Pang, Phillip S.; McHutchison, John G.; Muir, Andrew J.; Howell, Charles; Kowdley, Kris; Afdhal, Nezam; Reddy, K.... Journal: Hepatology Issue: Volume 63:Issue 2(2016:Feb.) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials. Issue 1 (1st June 2015) Authors: Alqahtani, Saleh A.; Afdhal, Nezam; Zeuzem, Stefan; Gordon, Stuart C.; Mangia, Alessandra; Kwo, Paul; Fried, Michael; Yang, Jenny C.; Ding, Xiao; Pang, Phillip S.; McHutchison, John G.; Pound, David; Reddy, K. Rajender; Marcellin, Patrick; Kowdley, Kris V.; Sulkowski, Mark Journal: Hepatology Issue: Volume 62:Issue 1(2015:Jul.) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials. Issue 1 (1st June 2015) Authors: Alqahtani, Saleh A.; Afdhal, Nezam; Zeuzem, Stefan; Gordon, Stuart C.; Mangia, Alessandra; Kwo, Paul; Fried, Michael; Yang, Jenny C.; Ding, Xiao; Pang, Phillip S.; McHutchison, John G.; Pound, David; Reddy, K. Rajender; Marcellin, Patrick; Kowdley, Kris V.; Sulkowski, Mark Journal: Hepatology Issue: Volume 62:Issue 1(2015:Jul.) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗